期刊文献+

独活对大鼠胶原诱导性关节炎的治疗作用 被引量:13

Effect of Heracleum on collagen induced arthritis in rats
下载PDF
导出
摘要 目的:观察不同剂量独活对胶原诱导性关节炎的治疗作用。方法:选择牛Ⅱ型胶原为免疫原,建立胶原诱导性关节炎模型,选取30只造模成功的大鼠随机分为5组:独活组[按顺序再分为低剂量(1.5 g.kg-1)组、中剂量(4.5 g.kg-1)组、大剂量(15 g.kg-1)组]和甲胺喋呤(B)组、生理盐水(C)组。采用关节炎指数评分对大鼠关节炎程度进行评分;采用酶联免疫吸附法测定各组大鼠血清基质金属蛋白酶-3、血管内皮生长因子,并评估可能的肝肾及胃黏膜副反应。结果:AI评分比较,中、小剂量独活组与生理盐水组差异无统计学意义;大剂量独活组小于生理盐水组(P<0.05),独活各剂量组差异无统计学意义;甲胺喋呤组均小于生理盐水组、小、中剂量独活组(分别P<0.01、P<0.05、P<0.05),而与大剂量独活组比较差异无统计学意义。血清血管内皮生长因子比较,独活各剂量组差异无统计学意义,但均显著低于生理盐水组(按大、中、小分别P<0.01、P<0.05、P<0.05);甲胺喋呤组显著低于生理盐水组及小剂量独活组(分别P<0.01、P<0.05),但与中、大剂量独活组比较差异无统计学意义。血清基质金属蛋白酶-3比较,各独活剂量组比较差异无统计学意义;独活小剂量组与生理盐水组差异无统计学意义;独活中、大剂量组均低于生理盐水组(均P<0.05);甲胺喋呤组低于生理盐水组及小剂量独活组(均P<0.01),但与中、大剂量独活组比较差异无统计学意义。各组肝功、肾功、血常规及胃病理检查均未见明显异常。结论:①独活大剂量能减轻胶原诱导性关节炎炎症,而中低剂量则无此作用;②独活中大剂量能明显降低血清血管内皮生长因子、基质金属蛋白酶-3水平;③独活大剂量在短期动物实验中无肝肾功能、血液、胃组织损害。 Objective :To observe the therapeutic effectiveness of different doses Heracleum on collagen induced arthritis (CIA) in rats. Methods:CIA rat model was established by subeutaneouly injecting bovine nasal cartilage II collagen. 30 CIA Rats were randomly di- vided into three Heracleum ( low, medium and high dose, A1 and A2 and A3 ) treated groups, MTX ( Methotrexate, B ) treated group, and control (C) group. The arthritic index(AI) of all rats were compared separately, the serum level of MMP-3, VEGF, AST, ALT, BUN, Cr were assayed, and the histology of gastric mucosal were examination. Result:In AI score, there was no difference between groupA2, groupA1 and groupC ;that in groupA3 were less than GroupB (P 〈 0.05 ,P 〈 0.01 ), there was no statistical difference in Heracleum groups. In the serum level of VEGF,all the group A1 and A2 and A3 and B were less than the groupC(P 〈0.05 ,P 〈0.05 ,P 〈0.01 ,P 〈0.01) ,but the differ- ences of groupA2 and groupA3 and groupB were not statistically significant. In the serum level of MMP-3, all the groupA2 and A3 and B were less than the groupC( P 〈 0.05 ,P 〈 0.05, P 〈 0.01 ) , but the differences of groupA2 and groupA3 and groupB were not statistically significant. In the serum level of AST, ALT, BUN, Cr and the histology of gastric mucosal, all groups showed no obvious abnormalities. Conclusion:①High dose of Heraclenm can reduce the inflammation of CIA rats ,while the low dose does not have this effect. ②Medium and high dose of Heracleum can significantly reduce the serum level of VEGF and MMP-3. ③For High dose of Heracleum , there are no damage of hepatic and renal function, blood and stomach in the short-term animal studies.
出处 《中医正骨》 2012年第2期6-8,共3页 The Journal of Traditional Chinese Orthopedics and Traumatology
基金 福建省厦门市卫生局青年创新课题基金资助项目[厦卫科教中医(2007)479号]
关键词 独活 关节炎 类风湿 动物实验 大鼠 Heracleum Collagen induced arthritis
  • 相关文献

参考文献5

  • 1Vogel HG,Vogel WH.药理实验指南—新药发现和药理学评价[M].杜冠华,李学军,张永祥,等译.北京:科学出版社,2001:577-589.
  • 2汤文璐 李俊 徐叔云 等.Ⅱ型胶原蛋白与弗氏完全佐剌大鼠关节炎模型的建立和比较.中国实验动物学报,1997,(1):1-6.
  • 3王晓霞,李小峰,王来远,胡学芳,张琳,李雪飞.类风湿关节炎血清基质金属蛋白酶-3水平及其影响因素的探讨[J].中华风湿病学杂志,2004,8(1):16-19. 被引量:31
  • 4Paleolog EM.Angiogenesis:a critical process in the pathogenesis of RA:a role for VEGF?[J].Br J Rheumatol,1996,35(10):917-919.
  • 5Maeno N,Takei S,Imanaka H.Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis[J].J Rheumatol,1999,26 (10):2244-2248.

二级参考文献16

  • 1Klimiuk PA,Sierakowski S,Latosiewicz R,et al.Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histologieal variants of rheumatoid synovitis. Rheumatology (Oxford),2002,41:78-87.
  • 2Yamanaka H,Matsuda Y,Tanaka M,et al. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement,in patients with early rheumatoid arthritis. Arthritis Rheum,2000,43:852-858.
  • 3Cunnane G,Fitz-Gerald O,Beeton C,et al. Early joint erosions and serum levels of matrix metalloproteinases 1,matrix metalloproteinases 3,and tissue inhibitor of metalloproteinases 1 in rheumatoid athritis.Arthritis Rheum,2001,44:2263 -2274.
  • 4Ishiguro N,Ito T,Obata K,et al. Determination of stromelysin-1,72 Kda type Ⅳ collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1),and TIMP-2 in synovial fluid and serum from patients with rheumatoidarthritis .J Rheumatol, 1996,23:1599-1604.
  • 5Wolfe F,Sharp JT.Radiographic outcome of recent-onset rheumatoid arthritis:a 19-year study of radiographic progression.Arthritis Rheum,1998,41:1571-1582.
  • 6Green MJ,Gough AK,Devlin J,et al. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology,2003,42:83-88.
  • 7Posthumus,MD,Limburg PC,Westra J. Serum matrix metalloproteinase 3in early rheumatoid arthritis is correlated with disease activity and radiological progression. J Rheumatol,2000,27:2761-2768.
  • 8Ribbens C,Andre B,Jaspar J.Matrix mettalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis.J Rheumatol,2000,27:888-893.
  • 9Zucker S,Hymovitz M,Conner C,et al. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tis-sues:clinical experimental applications.Ann NY Acad Sci, 1999,878:212-227.
  • 10Okada Y.Proteinases and matrix degradation. In:Kelley WN,Ruddy S,Harris ED,eds.Textbook of rheumatology.6th ed. Philadelphia:WB Saunders,2000.55-72.

共引文献30

同被引文献203

引证文献13

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部